InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Rowland Charles A Jr, Director. Insider active across 2 companies, notably Blueprint Medicines Corp. In total, 6 reports have been logged. Total volume traded: €2k. The latest transaction was filed on 2 August 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€785777 shares@ €1.0106100.0% of flow
Ordinary Shares
SEC:0001104659-21-100288·
€785777 shares@ €1.010650.0% of flow
Ordinary Shares
SEC:0001104659-21-100288:0·
017,500 shares0
Ordinary Shares
SEC:0001104659-21-098427·
017,500 shares0
Ordinary Shares
SEC:0001104659-21-098427:0·
02,250 shares0
Common Stock
SEC:0001179110-21-006417·
02,250 shares0
Common Stock
SEC:0001179110-21-006417:0·
6 of 6 declarations
About Rowland Charles A Jr
Charles A. Rowland Jr serves as a Director at Blueprint Medicines Corp and Nabriva Therapeutics plc. In this role, he participates in the governance of the companies and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions, ensuring that the companies remain aligned with their growth objectives.
